Natco Announces Launch of Generic Tamiflu

Natco Pharma has announced the launch of a generic version of Tamiflu oral capsules for the United States market. According to the company’s regulatory filing, this is the first generic equivalent of Tamiflu capsules. Natco is launching the antiviral generic through Alvogen, its marketing partner. According to IMS Health data, Tamiflu capsules have annual US sales of $403 million.

Read the source article at The Hindu